PHAR
Pharming Group NV
NASDAQ: PHAR · HEALTHCARE · BIOTECHNOLOGY
$16.53
+1.07% today
Updated 2026-04-30
Market cap
$1.16B
P/E ratio
408.88
P/S ratio
3.07x
EPS (TTM)
$0.04
Dividend yield
—
52W range
$9 – $21
Volume
0.0M
Pharming Group NV (PHAR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-25.89M | $-31.69M | $-14.21M | $-27.24M | $-6.89M | $-20.34M | $-13.58M | $-11.45M | $-6.42M | $-17.95M | $-10.52M | $45.84M | $46.19M | $74.15M | $83.63M | $37.84M | $22.46M | $-17.30M | $-1.79M | $50.07M |
| Capital expenditures | $4.16M | $978319.00 | $1.13M | $435555.00 | $1.21M | $1.37M | $812018.00 | $28998.00 | $187265.00 | $981785.00 | $1.59M | $7.25M | $4.31M | $25.45M | $15.30M | $16.72M | $1.98M | $1.46M | $796000.00 | $751090.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | — | — | — | — | — | — | $4.44M | $6.54M | $9.06M | $6.39M | $9.25M | $11.25M | $13.77M |
| Free cash flow | $-30.05M | $-32.67M | $-15.35M | $-27.68M | $-8.09M | $-21.71M | $-14.39M | $-11.48M | $-6.61M | $-18.94M | $-12.11M | $38.59M | $41.87M | $48.70M | $68.33M | $21.13M | $20.48M | $-18.77M | $-2.59M | $49.31M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | $0.00 | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |